Is combining therapy with indomethacin and epinephrine useful for preventing post-ERCP pancreatitis? The answer from a meta-analysis

Eur J Gastroenterol Hepatol. 2020 Mar;32(3):459-460. doi: 10.1097/MEG.0000000000001653.

Authors

Passisd Laoveeravat^{1

2}, Abhilash Perisetti³, Mauricio Garcia-Saenz-de-Sicilia³, Shashank Garg³, Benjamin Tharian³

Affiliations

¹ Department of Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, Texas, USA.
² Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
³ Division of Gastroenterology, University of Arkansas for Medical Sciences, Little rock, Arkansas, USA.

PMID: 32011390
DOI: 10.1097/MEG.0000000000001653

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

Administration, Rectal
Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Cholangiopancreatography, Endoscopic Retrograde / adverse effects
Epinephrine
Humans
Indomethacin* / adverse effects
Pancreatitis* / etiology
Pancreatitis* / prevention & control

Substances

Anti-Inflammatory Agents, Non-Steroidal
Indomethacin
Epinephrine